Tirzepatide as a New Treatment for Sleep Apnea and Metabolic Problems

Tirzepatide may improve the apnea-hypopnea index and oxygenation in patients with obstructive sleep apnea.

• Obstructive sleep apnea is linked to obesity and metabolic dysfunction, leading to various health complications.
• Tirzepatide is a dual receptor agonist that could reduce fat deposition around the upper airway.
• Improvements in insulin sensitivity and systemic inflammation have been associated with tirzepatide.
• Emerging clinical studies suggest potential benefits of tirzepatide for managing obstructive sleep apnea.
• The review highlights the mechanisms by which tirzepatide may alleviate the severity of obstructive sleep apnea.

Simplified